220 related articles for article (PubMed ID: 27427494)
1. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
[TBL] [Abstract][Full Text] [Related]
2. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
[TBL] [Abstract][Full Text] [Related]
4. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
[TBL] [Abstract][Full Text] [Related]
6. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
[TBL] [Abstract][Full Text] [Related]
8. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
[TBL] [Abstract][Full Text] [Related]
10. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
Foreman JE; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Cancer Lett; 2010 Feb; 288(2):219-25. PubMed ID: 19660859
[TBL] [Abstract][Full Text] [Related]
11. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.
Borland MG; Krishnan P; Lee C; Albrecht PP; Shan W; Bility MT; Marcus CB; Lin JM; Amin S; Gonzalez FJ; Perdew GH; Peters JM
Carcinogenesis; 2014 Jul; 35(7):1602-12. PubMed ID: 24639079
[TBL] [Abstract][Full Text] [Related]
12. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
Letavernier E; Perez J; Joye E; Bellocq A; Fouqueray B; Haymann JP; Heudes D; Wahli W; Desvergne B; Baud L
J Am Soc Nephrol; 2005 Aug; 16(8):2395-402. PubMed ID: 15944338
[TBL] [Abstract][Full Text] [Related]
14. Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.
Peters JM; Hollingshead HE; Gonzalez FJ
Clin Sci (Lond); 2008 Aug; 115(4):107-27. PubMed ID: 18616431
[TBL] [Abstract][Full Text] [Related]
15. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.
Marin HE; Peraza MA; Billin AN; Willson TM; Ward JM; Kennett MJ; Gonzalez FJ; Peters JM
Cancer Res; 2006 Apr; 66(8):4394-401. PubMed ID: 16618765
[TBL] [Abstract][Full Text] [Related]
16. PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury.
Qian B; Wang C; Li X; Ma P; Dong L; Shen B; Wu H; Li N; Kang K; Ma Y
Liver Int; 2023 Dec; 43(12):2808-2823. PubMed ID: 37833850
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.
Foreman JE; Chang WC; Palkar PS; Zhu B; Borland MG; Williams JL; Kramer LR; Clapper ML; Gonzalez FJ; Peters JM
Mol Carcinog; 2011 Nov; 50(11):884-900. PubMed ID: 21400612
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
[TBL] [Abstract][Full Text] [Related]
19. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
[TBL] [Abstract][Full Text] [Related]
20. PPARβ/δ modulates ethanol-induced hepatic effects by decreasing pyridoxal kinase activity.
Goudarzi M; Koga T; Khozoie C; Mak TD; Kang BH; Fornace AJ; Peters JM
Toxicology; 2013 Sep; 311(3):87-98. PubMed ID: 23851158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
